glp-1 work and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? The GLP-1 revolution: What UAB
Description
doi: 10.1016/j.coph.2013.08.013
As much as 40% of people using these drugs give up after the first month. A second hormone released after eating is glucose-dependent insulinotropic peptide (GIP)
Data reported in one study only
The data shows that discontinuing GLP-1 medications leads to significant weight regain in the majority of patients
If you used an alcohol swab, be sure to let the area dry completely before testing
GLP-1 therapy isnt for everyone with RA
